吉田 一彦
   Department   School of Medicine(Tokyo Women's Medical University Hospital), School of Medicine
   Position   Assistant Professor
Article types Original article
Language English
Peer review Peer reviewed
Title Immediate progressive disease in patients with metastatic renal cell carcinoma treated with nivolumab: a multi-institution retrospective study.
Journal Formal name:Targeted oncology
Abbreviation:Target Oncol
ISSN code:(1776-260X)1776-2596(Linking)
Domestic / ForeginForegin
Volume, Issue, Page 13(5),pp.611-619
Author and coauthor ISHIHARA Hiroki†, KONDO Tsunenori, TAKAGI Toshio, TACHIBANA Hirokazu, FUKUDA HIronori, YOSHIDA Kazuhiko, IIZUKA Jumpei, KOBAYASHI Hirohito, TANABE Kazunari
Publication date 2018/10
Summary The development of immediate PD in mRCC patients treated with nivolumab can severely worsen patient prognosis. Sex, MSKCC score, and prior-line time to progression may be involved in the development of immediate PD. Prospective studies are needed to further assess these findings.
DOI 10.1007/s11523-018-0591-0
PMID 30232691